A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma

Clinical trial NCT07372287 · RECRUITING

Trial details

NCT number: NCT07372287
Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Moderate to Severe Asthma

Start date: 2026-01-23
Primary completion: 2028-12-31
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.